4.8 Review

Haemostatic alterations and management of haemostasis in patients with cirrhosis

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus

Ellen G. Driever et al.

Summary: The study found that portal vein thrombosis in cirrhotic patients is mainly composed of intimal fibrosis, with fibrin-rich thrombus present in only one-third of cases. Clinical characteristics showed no significant association with the presence of fibrin-rich thrombi.

HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Mortality and Hepatic Decompensation in Patients With Cirrhosis and Atrial Fibrillation Treated With Anticoagulation

Marina Serper et al.

Summary: The study found that warfarin and DOACs were associated with reduced all-cause mortality in patients with cirrhosis and atrial fibrillation. In secondary analysis, DOACs had a lower incidence of bleeding compared to warfarin. Future studies should further investigate these observed associations.

HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Rates of Bleeding and Discontinuation of Direct Oral Anticoagulants in Patients With Decompensated Cirrhosis

Joseph F. Mort et al.

Summary: This retrospective study investigated the use of DOACs in patients with cirrhosis and found that patients with decompensated cirrhosis have significant bleeding and discontinuation rates. Pretreatment laboratory parameters, DOAC dose, and Child-Turcotte-Pugh class were not associated with bleeding, but hepatocellular carcinoma was linked to major bleeding.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Hematology

The ADAMTS13-von Willebrand factor axis in COVID-19 patients

Ilaria Mancini et al.

Summary: Severe COVID-19 patients exhibit an increased risk of thromboembolic events, with evidence of microthrombosis in the lungs of deceased patients. The study found a significant alteration of the VWF-ADAMTS13 axis in COVID-19 patients, with an elevated VWF:Ag to ADAMTS13 activity ratio strongly associated with disease severity, enhancing the hypercoagulable state and risk of microthrombosis in these patients.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Article Hematology

Prophylactic fresh frozen plasma and platelet transfusion have a prothrombotic effect in patients with liver disease

Fien A. von Meijenfeldt et al.

Summary: The study analyzed the effects of FFP and platelet transfusions on patients with liver disease-associated hemostatic changes in a clinical setting. Results showed an increase in thrombin generation and platelet counts in these patients following transfusions, indicating a prothrombotic effect. However, the necessity and clinical relevance of these transfusions remain questionable.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Review Gastroenterology & Hepatology

AGA Technical Review on Coagulation in Cirrhosis

Nicolas M. Intagliata et al.

GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis

Robert S. O'Shea et al.

GASTROENTEROLOGY (2021)

Review Gastroenterology & Hepatology

Current knowledge and management of portal vein thrombosis in cirrhosis

Marco Senzolo et al.

Summary: Portal vein thrombosis (PVT) is a complication of cirrhosis with increasing incidence related to the severity of cirrhosis. Various risk factors contribute to PVT occurrence and progression. While the impact of complete PVT on liver transplant outcomes is clear, its effect on cirrhosis progression remains uncertain. Treatment options vary based on individual patient characteristics and thrombus features.

JOURNAL OF HEPATOLOGY (2021)

Article Hematology

The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease

Ton Lisman et al.

Summary: Patients with liver diseases experience complex alterations in their hemostatic system, leading to a fragile balance between bleeding and thrombotic events. Although traditionally classified as acquired bleeding disorders, laboratory observations have shown that they are also prone to developing both bleeding and thrombotic events.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Article Hematology

Treatment of bleeding in patients with liver disease

Patrick G. Northup et al.

Summary: Patients with cirrhosis often have complex changes in their hemostatic system. Routine diagnostic tests may not accurately reflect their hemostatic competence and correction of laboratory values for hemostasis is not recommended for bleeding prevention. Prohemostatic therapy is not the first line of management for bleeding patients with cirrhosis.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Review Cardiac & Cardiovascular Systems

Safety of direct oral anticoagulants in patients with mild to moderate cirrhosis: a systematic review and meta-analysis

Sarah A. Nisly et al.

Summary: Several studies have shown that there is no significant difference in major bleeding events between traditional anticoagulation and DOACs in patients with cirrhosis, suggesting that the risk of using DOACs in this patient population is similar to that of traditional anticoagulation.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

Article Gastroenterology & Hepatology

Fresh frozen plasma transfusion in acute variceal haemorrhage: Results from a multicentre cohort study

Arpan Mohanty et al.

Summary: A study found that FFP transfusion in AVH patients was associated with higher mortality, failure to control bleeding, and longer length of stay.

LIVER INTERNATIONAL (2021)

Article Gastroenterology & Hepatology

Risk and Outcome of Venous and Arterial Thrombosis in Patients With Cirrhosis: A Danish Nation-wide Cohort Study

Peter Jepsen et al.

Summary: Patients with cirrhosis have an increased risk of venous thromboembolism (VTE) and ischemic stroke (IS), but not acute myocardial infarction (AMI). Decompensation in cirrhosis only increases the risk of AMI. The mortality rate after thrombosis is higher in cirrhosis patients and they are less likely to receive antithrombotic treatment.

HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors

Fanny Turon et al.

Summary: In patients with cirrhosis, the main predictive factors for portal vein thrombosis (PVT) development are related to the severity of portal hypertension. There is no significant relationship between PVT development and other clinical, biochemical, inflammatory, and acquired or hereditary hemostatic parameters.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Safety of direct oral anticoagulants in patients with advanced liver disease

Georg Semmler et al.

Summary: The study findings suggest that DOACs should be used cautiously in patients with advanced liver disease due to a significant rate of spontaneous bleeding events. More specifically, spontaneous bleeding is more common in ACLD patients, and factors like CPS grade and occurrence of bleeding during DOAC treatment are associated with their overall survival.

LIVER INTERNATIONAL (2021)

Article Gastroenterology & Hepatology

Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure

Elena Campello et al.

Summary: This study investigated coagulation alterations in ACLF patients compared to AD patients, finding that ACLF patients had lower platelet count, longer INR and activated partial thrombin time. ROTEM results indicated a more pronounced hypocoagulable state in ACLF patients. No correlation was found between these alterations and bleeding complications.

LIVER INTERNATIONAL (2021)

Editorial Material Gastroenterology & Hepatology

Fresh frozen plasma in treating acute variceal bleeding: Not effective and likely harmful

Ton Lisman et al.

LIVER INTERNATIONAL (2021)

Article Hematology

Thrombin generation is associated with ischemic stroke at a young age

Samantha J. Donkel et al.

Summary: Thrombin generation parameters are associated with a first IS in young patients, with LT, TTP, and TTT being associated with IS in men but not in women. Further prospective studies are needed to clarify the role of TG in IS.

THROMBOSIS RESEARCH (2021)

Article Gastroenterology & Hepatology

A multicenter analysis of the role of prophylactic transfusion of blood products in patients with cirrhosis and esophageal varices undergoing endoscopic band ligation

Annabel Blasi et al.

Summary: The study evaluated the prophylactic administration of blood products in outpatients with cirrhosis undergoing endoscopic band ligation in Spain. The results indicated that bleeding after band ligation is uncommon and not related to coagulation tests or prophylactic transfusion.

JHEP REPORTS (2021)

Article Gastroenterology & Hepatology

Thromboelastography-guided Blood Product Transfusion in Cirrhosis Patients With Variceal Bleeding A Randomized Controlled Trial

Gyanranjan Rout et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2020)

Article Gastroenterology & Hepatology

Ulcer bleeding after band ligation of esophageal varices: Risk factors and prognosis

Eva Duenas et al.

DIGESTIVE AND LIVER DISEASE (2020)

Article Gastroenterology & Hepatology

ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation

Douglas A. Simonetto et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Letter Gastroenterology & Hepatology

Interpreting Hemostatic Profiles Assessed With Viscoelastic Tests in Patients With Cirrhosis

Ton Lisman

JOURNAL OF CLINICAL GASTROENTEROLOGY (2020)

Editorial Material Gastroenterology & Hepatology

Nails in the coffin of fresh frozen plasma to prevent or treat bleeding in cirrhosis?

William Bernal et al.

JOURNAL OF HEPATOLOGY (2020)

Article Hematology

Hypercoagulability (thrombin generation) in patients with cirrhosis is detected with ST-Genesia

Laurie Talon et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Hematology

Thrombin Generation and Cirrhosis: State of the Art and Perspectives

Aurelien Lebreton et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2020)

Article Hematology

Netting Liver Disease: Neutrophil Extracellular Traps in the Initiation and Exacerbation of Liver Pathology

Fien A. von Meijenfeldt et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2020)

Article Gastroenterology & Hepatology

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta-Analysis

Francesco Violi et al.

HEPATOLOGY COMMUNICATIONS (2020)

Article Gastroenterology & Hepatology

A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis

Kryssia I. Rodriguez-Castro et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)

Review Gastroenterology & Hepatology

Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis

Nicolas M. Intagliata et al.

GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Acute kidney injury is associated with low factor XIII in decompensated cirrhosis

Nicolas M. Intagliata et al.

DIGESTIVE AND LIVER DISEASE (2019)

Review Gastroenterology & Hepatology

AGA Clinical Practice Update: Coagulation in Cirrhosis

Jacqueline G. O'Leary et al.

GASTROENTEROLOGY (2019)

Article Cardiac & Cardiovascular Systems

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease

So-Ryoung Lee et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Gastroenterology & Hepatology

Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis

I. Pettinari et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)

Review Hematology

Inherited thrombophilia and portal vein thrombosis in cirrhosis: A systematic review and meta-analysis

Steven D. Ma et al.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2019)

Review Gastroenterology & Hepatology

Anticoagulation in the cirrhotic patient

Laura Turco et al.

JHEP REPORTS (2019)

Article Medicine, General & Internal

Suboptimal use of pharmacological venous thromboembolism prophylaxis in cirrhotic patients

Linda S. Yang et al.

INTERNAL MEDICINE JOURNAL (2018)

Article Medicine, General & Internal

Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function

Bernhard Scheiner et al.

WIENER KLINISCHE WOCHENSCHRIFT (2018)

Article Critical Care Medicine

Antithrombotic Therapy for Atrial Fibrillation CHEST Guideline and Expert Panel Report

Gregory Y. H. Lip et al.

CHEST (2018)

Review Gastroenterology & Hepatology

Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis

Filippo Schepis et al.

SEMINARS IN LIVER DISEASE (2018)

Article Hematology

The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis

Justine Hum et al.

EUROPEAN JOURNAL OF HAEMATOLOGY (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Final Analysis of a 61-Patient Cohort

Bartley Thornburg et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2017)

Review Hematology

The risk of venous thromboembolism in patients with cirrhosis A systematic review and meta-analysis

Pasquale Ambrosino et al.

THROMBOSIS AND HAEMOSTASIS (2017)

Review Hematology

Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases

Ton Lisman et al.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2017)

Article Gastroenterology & Hepatology

Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation

N. M. Intagliata et al.

DIGESTIVE DISEASES AND SCIENCES (2016)

Article Gastroenterology & Hepatology

Coagulation Parameters and Major Bleeding in Critically Ill Patients With Cirrhosis

Andreas Drolz et al.

HEPATOLOGY (2016)

Letter Gastroenterology & Hepatology

Prediction of bleeding in cirrhosis patients: Is the forecast any clearer?

Nicolas M. Intagliata et al.

HEPATOLOGY (2016)

Review Gastroenterology & Hepatology

Nontumoral portal vein thrombosis in patients awaiting liver transplantation

Hui Chen et al.

LIVER TRANSPLANTATION (2016)

Article Hematology

Coagulopathy of Acute Sepsis

Nicola Semeraro et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2015)

Article Gastroenterology & Hepatology

Cirrhosis is Associated with an Increased 30-Day Mortality After Venous Thromboembolism

Kirstine Kobberoe Sogaard et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2015)

Letter Gastroenterology & Hepatology

Correction of Hemostatic Abnormalities and Portal Pressure Variations in Patients With Cirrhosis

Edoardo G. Giannini et al.

HEPATOLOGY (2014)

Article Gastroenterology & Hepatology

Portal Vein Thrombosis in Patients with End Stage Liver Disease Awaiting Liver Transplantation: Outcome of Anticoagulation

K. T. Werner et al.

DIGESTIVE DISEASES AND SCIENCES (2013)

Article Medicine, General & Internal

Transfusion Strategies for Acute Upper Gastrointestinal Bleeding

Candid Villanueva et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Gastroenterology & Hepatology

Efficacy and Safety of Anticoagulation on Patients With Cirrhosis and Portal Vein Thrombosis

Maria Gabriela Delgado et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)

Article Gastroenterology & Hepatology

Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis

Erica Villa et al.

GASTROENTEROLOGY (2012)

Review Hematology

Adverse effects of plasma transfusion

Suchitra Pandey et al.

TRANSFUSION (2012)

Review Medicine, General & Internal

MECHANISMS OF DISEASE The Coagulopathy of Chronic Liver Disease

Armando Tripodi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Gastroenterology & Hepatology

Predictive factors of bleeding related to post-banding ulcer following endoscopic variceal ligation in cirrhotic patients: a case-control study

G. Vanbiervliet et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)

Editorial Material Gastroenterology & Hepatology

Hemostasis and thrombosis in patients with liver disease: The ups and downs

Ton Lisman et al.

JOURNAL OF HEPATOLOGY (2010)

Article Cardiac & Cardiovascular Systems

Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients

T. N. Bongers et al.

ATHEROSCLEROSIS (2009)

Article Gastroenterology & Hepatology

A Prospective Study of Conventional and Expanded Coagulation Indices in Predicting Ulcer Bleeding After Variceal Band Ligation

Evandra Cristina Vieira Da Rocha et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)

Article Gastroenterology & Hepatology

An Imbalance of Pro- vs Anti-Coagulation Factors in Plasma From Patients With Cirrhosis

Armando Tripodi et al.

GASTROENTEROLOGY (2009)

Review Transplantation

The two tales of coagulation in liver transplantation

Nienke Warnaar et al.

CURRENT OPINION IN ORGAN TRANSPLANTATION (2008)

Article Radiology, Nuclear Medicine & Medical Imaging

US-guided placement of central vein catheters in patients with disorders of hemostasis

Fahri Tercan et al.

EUROPEAN JOURNAL OF RADIOLOGY (2008)

Article Hematology

Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis

Masahito Uemura et al.

THROMBOSIS AND HAEMOSTASIS (2008)

Article Gastroenterology & Hepatology

Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism

PG Northup et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)